Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.
Neurogenic lower urinary tract dysfunction, which is common in patients with multiple sclerosis, has a significant impact on quality of life. In this study we sought to determine brain activity processes during the micturition cycle in female patients with multiple sclerosis and neurogenic lower urinary tract dysfunction.



We report brain activity on functional magnetic resonance imaging and simultaneous urodynamic testing in 23 ambulatory female patients with multiple sclerosis. Individual functional magnetic resonance imaging activation maps at strong desire to void and at initiation of voiding were calculated and averaged at Montreal Neuroimaging Institute. Areas of significant activation were identified in these average maps. Subgroup analysis was performed in patients with elicitable neurogenic detrusor overactivity or detrusor-sphincter dyssynergia.



Group analysis of all patients at strong desire to void yielded areas of activation in regions associated with executive function (frontal gyrus), emotional regulation (cingulate gyrus) and motor control (putamen, cerebellum and precuneus). Comparison of the average change in activation between previously reported healthy controls and patients with multiple sclerosis showed predominantly stronger, more focal activation in the former and lower, more diffused activation in the latter. Patients with multiple sclerosis who had demonstrable neurogenic detrusor overactivity and detrusor-sphincter dyssynergia showed a trend toward distinct brain activation at full urge and at initiation of voiding respectively.



We successfully studied brain activation during the entire micturition cycle in female patients with neurogenic lower urinary tract dysfunction and multiple sclerosis using a concurrent functional magnetic resonance imaging/urodynamic testing platform. Understanding the central neural processes involved in specific parts of micturition in patients with neurogenic lower urinary tract dysfunction may identify areas of interest for future intervention.
Department of Urology, Houston Methodist Hospital, Houston, Texas. Electronic address: rkhavari@houstonmethodist.org.
Rose
R
Khavari
MRI Core, Methodist Research Institute, Houston, Texas.
Christof
C
Karmonik
Innovative Urology Practice of New York, Queens, New York.
Michael
M
Shy
Sutter Health, Santa Rosa, California.
Sophie
S
Fletcher
Department of Urology, Houston Methodist Hospital, Houston, Texas.
Timothy
T
Boone
D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging / Q000503:physiopathology*; D001931:Brain Mapping / Q000379:methods; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000503:physiopathology*; D010865:Pilot Projects; D011788:Quality of Life; D001750:Urinary Bladder, Neurogenic / Q000503:physiopathology*; D053201:Urinary Bladder, Overactive / Q000503:physiopathology*; D014554:Urination / Q000502:physiology*; D014563:Urodynamics / Q000502:physiology
brain mapping; magnetic resonance imaging; multiple sclerosis; urinary bladder; urodynamics
Nat Rev Urol. 2016 May;13(5):275-88
27030526
Neurourol Urodyn. 2012 Jun;31(5):652-8
22473921
J Urol. 1998 Mar;159(3):972-6
9474196
Neurourol Urodyn. 2013 Nov;32(8):1047-57
23757108
Neuroimage. 2003 Jul;19(3):532-44
12880785
Neurourol Urodyn. 2008;27(6):466-74
18092336
Pain. 2014 Dec;155(12):2502-9
25242566
Neurourol Urodyn. 2017 Jan;36(1):155-159
26445209
J Neurosci. 2009 Oct 7;29(40):12574-83
19812332
J Urol. 2014 Oct;192(4):1149-54
24769029
Lancet Neurol. 2015 Jul;14(7):720-32
26067125
Neurourol Urodyn. 2016 Jan;35(1):48-54
25327401
Neurology. 1983 Nov;33(11):1444-52
6685237
Brain. 1998 Nov;121 ( Pt 11):2033-42
9827764
Nat Rev Urol. 2015 Dec;12(12):695-705
26620610
Urol Clin North Am. 2014 Aug;41(3):439-44, ix
25063600
J Urol. 2012 Aug;188(2):474-9
22698619
Int J Urol. 2015 Apr;22(4):342-8
25693685